Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer

British Journal of Cancer

Volumn 92, Issue 4, 2005, Pages 775-783

  Rollin, J ^a   Iochmann, S ^a   Blechet C ^a   Hube F ^a   Regina S ^a   Guyetant S ^a   Lemarie E ^a   Reverdiau, P ^a   Gruel, Y ^a  

^a INSERM   (France)

Author keywords

NSCLC; Promoter hypermethylation; Real time PCR; TFPI 2

Indexed keywords

MESSENGER RNA; METALLOPROTEINASE; PLACENTA PROTEIN 5; PLASMIN; RESTRICTION ENDONUCLEASE; SERINE PROTEINASE INHIBITOR; COMPLEMENTARY DNA; DNA; GLYCOPROTEIN; RNA; TISSUE-FACTOR-PATHWAY INHIBITOR 2;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; ENZYME ACTIVATION; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ADULT; AGED; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SYNTHESIS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA METHYLATION; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, MESSENGER; RNA, NEOPLASM;

EID: 14944351394     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602298     Document Type: Article

References (35)

1. Atkin NB, Baker MC (1993) Chromosome 7q deletions: observations on 13 malignant tumors. Cancer Genet Cytogenet 67: 123-125
2. Chand HS, Du X, Ma D, Inzunza HD, Kamei S, Foster D, Brodie S, Kisiel W (2004) The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice. Blood 103: 1069-1077
3. Cox G, Steward WP, O'Byrne KJ (1999) The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax 54: 169-179
4. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174
5. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797
6. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G, Hartwell L (2003) The case for early detection. Nat Rev Cancer 3: 243-252
7. Fraga MF, Esteller M (2002) DNA methylation: a profile of methods and applications. Biotechniques 33: 632, 634, 636-649
8. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054
9. Hube F, Reverdiau P, Iochmann S, Cherpi-Antar C, Gruel Y (2003a) Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb Res 109: 207-215
10. Hube F, Reverdiau P, Iochmann S, Rollin J, Cherpi-Antar C, Gruel Y (2003b) Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells. Biol Chem 384: 1029-1034
11. Hube F, Reverdiau P, Iochmann S, Trassard S, Thibault G, Gruel Y (2003c) Demonstration of a tissue factor pathway inhibitor 2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas. Biol Reprod 68: 1888-1894
12. Iochmann S, Reverdiau-Moalic P, Beaujean S, Rideau E, Lebranchu Y, Bardos P, Gruel Y (1999) Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction. Thromb Res 94: 165-173
13. Iochmann S, Reverdiau-Moalic P, Hube F, Bardos P, Gruel Y (2002) Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR. Thromb Res 105: 217-223
14. Izumi H, Takahashi C, Oh J, Noda M (2000) Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes. FEBS Lett 481: 31-36
15. Kast C, Wang M, Whiteway M (2003) The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. J Biol Chem 278: 6787-6794
16. Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS (2003) Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 22: 4509-4516
17. Konduri SD, Tasiou A, Chandrasekar N, Nicolson GL, Rao JS (2000) Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion. Clin Exp Metast 18: 303-308
18. Konduri SD, Tasiou A, Chandrasekar N, Rao JS (2001) Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. Int J Oncol 18: 127-131
19. Lakka SS, Konduri SD, Mohanam S, Nicolson GL, Rao JS (2000) In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clin Exp Metast 18: 239-244
20. Miyagi Y, Yasumitsu H, Eki T, Miyata S, Kkawa N, Hirahara F, Aoki I, Misugi K, Miyazaki K (1996) Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis. Genomics 35: 267-268
21. Mountain CF (1997) Revisions in the International System for staging lung cancer. Chest 111: 1710-1717
22. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J, Testa JR (2001) Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 31: 282-287
23. Rao CN, Lakka SS, Kin Y, Konduri SD, Fuller GN, Mohanam S, Rao JS (2001) Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clin Cancer Res 7: 570-576
24. Rao CN, Mohanam S, Puppala A, Rao JS (1999) Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor. Biochem Biophys Res Commun 255: 94-98
25. Rao CN, Reddy P, Liu Y, O'Toole E, Reeder D, Foster DC, Kisiel W, Woodley DT (1996) Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys 335: 82-92
26. Rao CN, Reddy P, Reeder DJ, Liu Y, Stack SM, Kisiel W, Woodley DT (2000) Prokaryotic expression, purification, and reconstitution of biological activities (antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2. Biochem Biophys Res Commun 276: 1286-1294
27. Rao CN, Segawa T, Navari JR, Xu L, Srivastava S, Moul JW, Phillips B (2003) Methylation of TFPI-2 gene is not the sole cause of its silencing. Int J Oncol 22: 843-848
28. Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L (2000) Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 92: 1511-1516
29. Tasiou A, Konduri SD, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Obeyesekere M, Rao JS (2001) A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Int J Oncol 19: 591-597
30. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E (1999) World Health Organization Classification of Lung and Pleural Tumors. Springer-Verlag: Berlin
31. Tycko B (2000) Epigenetic gene silencing in cancer. J Clin Invest 105: 401-407
32. Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR, Shepherd FA, Minden MD, Tsao MS (2002) Novel candidate tumor marker genes for lung adenocarcinoma. Oncogene 21: 7598-7604
33. Wojtukiewicz MZ, Sierko E, Zimnoch L, Kozlowski L, Kisiel W (2003) Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Thromb Haemost 90: 140-146
34. Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T (2003) Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 94: 589-592
35. Zochbauer-Muller S, Gazdar AF, Minna JD (2002) Molecular pathogenesis of lung cancer. Annu Rev Physiol 64: 681-708